Jean M Connors
Overview
Explore the profile of Jean M Connors including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
243
Citations
6994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Helms J, Frere C, Thiele T, Tanaka K, Neal M, Steiner M, et al.
J Thromb Haemost
. 2025 Mar;
PMID: 40057415
No abstract available.
2.
Gouin-Thibault I, Castellucci L, Connors J, Hardy M, Mansour A, Siguret V, et al.
J Thromb Haemost
. 2025 Feb;
PMID: 39984159
Background: Unfractionated heparin (UFH) remains the anticoagulant of choice in critically ill patients. However, its laboratory monitoring and clinical management are particularly challenging. Objectives: Our objective was to describe current...
3.
4.
Gustafsson F, Uriel N, Netuka I, Katz J, Pagani F, Connors J, et al.
JAMA Cardiol
. 2025 Jan;
10(3):235-242.
PMID: 39774588
Importance: The Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure (ARIES-HM3) study demonstrated that aspirin may be safely eliminated from the antithrombotic regimen after...
5.
Di Vece D, Valgimigli M, Barnathan E, Connors J, Cools F, Held U, et al.
Res Pract Thromb Haemost
. 2024 Dec;
8(8):102613.
PMID: 39698185
Background: The global impact of the COVID-19 pandemic has prompted the search for strategies to improve outcomes in affected individuals, including those initially managed in outpatient settings. Thromboembolic events have...
6.
Maier C, Connors J, Levy J
Hematology Am Soc Hematol Educ Program
. 2024 Dec;
2024(1):186-191.
PMID: 39643992
The term heparin resistance is likely best defined as the failure of an appropriate dose of unfractionated heparin (UFH) to achieve a predetermined level of anticoagulation. Unfortunately, and despite many...
7.
Zoller B, Connors J
Haematologica
. 2024 Dec;
109(12):3852-3859.
PMID: 39618295
Multimorbidity, i.e., the presence of two or more long-term health conditions, is challenging for healthcare systems worldwide. A related term is comorbidity. This denotes any condition that has existed or...
8.
Ainle F, Middeldorp S, Hickman A, Clark C, Ageno W, Casais P, et al.
J Thromb Haemost
. 2024 Nov;
23(2):361-367.
PMID: 39603386
No abstract available.
9.
Shimony S, Raman H, Flamand Y, Keating J, Paolino J, Valtis Y, et al.
Blood Cancer J
. 2024 Nov;
14(1):191.
PMID: 39482298
Asparaginase (ASP)-containing regimens for acute lymphoblastic leukemia (ALL) are associated with venous thromboembolism (VTE). We evaluated the prevalence, risk factors, role of prophylaxis and clinical impact of VTE among adolescents...
10.
Uno H, Xiong H, Cronin C, Schrag D, Connors J
Thromb Res
. 2024 Oct;
244:109184.
PMID: 39406159
Introduction: Patients with cancer have an increased risk of developing venous thromboembolism (VTE) but also have an increased risk of both recurrent VTE and bleeding with anticoagulation compared to anticoagulated...